Literature DB >> 2097090

UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors.

.   

Abstract

The prevalence of various diabetic complications, their association with each other and with many risk factors, has been assessed in 2,337 newly diagnosed Type 2 diabetic patients. The patients entered into the UK Prospective Diabetes Study were aged between 25 and 65 (mean age 52 yr) and 33% had either an abnormal ECG or retinopathy. Different macrovascular complications such as strokes, heart attacks or abnormal ECG, and peripheral vascular disease showed little association one with another, and each was associated predominantly with different risk factors, e.g., strokes with hypertension, heart attacks with hypertriglyceridaemia and peripheral vascular disease with smoking and a low HDL cholesterol. Retinopathy was associated with reduced vibration perception but not with other complications. Reduced vibration perception and absent reflexes were associated with absent foot pulses and ischaemic skin changes, raising the possibility of a macrovascular, as well as microvascular, contribution to peripheral neuropathy. Microalbuminuria was associated with hypertension, which might be a factor predisposing to renal microvascular disease or be a consequence of it. Microalbuminuria was also associated with an abnormal ECG. Retinopathy, with exudates and or haemorrhages rather than just microaneurysms, was associated with hyperglycaemia. The occurrence of a particular complication in a diabetic patient is probably dependent on a combination of specific risk factors, many of which are related to, and probably affected by, potentially avoidable factors such as hyperglycaemia, obesity, smoking and hypertension.

Entities:  

Mesh:

Year:  1990        PMID: 2097090

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  46 in total

Review 1.  Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria.

Authors:  N J Wareham; S J Griffin
Journal:  BMJ       Date:  2001-04-21

2.  Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy.

Authors:  M Tyrberg; U Lindblad; A Melander; M Lövestam-Adrian; V Ponjavic; S Andréasson
Journal:  Doc Ophthalmol       Date:  2011-11-06       Impact factor: 2.379

3.  Metabolic syndrome.

Authors:  Kamlesh Khunti; Melanie Davies
Journal:  BMJ       Date:  2005-11-19

4.  The answer to diabetes prevention: science, surgery, service delivery, or social policy?

Authors:  Ruth Colagiuri; Stephen Colagiuri; Derek Yach; Stig Pramming
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

5.  Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort.

Authors:  R K Simmons; M Rahman; R W Jakes; M F Yuyun; A R Niggebrugge; S H Hennings; D R R Williams; N J Wareham; S J Griffin
Journal:  Diabetologia       Date:  2010-10-27       Impact factor: 10.122

Review 6.  Telemedicine in Complex Diabetes Management.

Authors:  Marie E McDonnell
Journal:  Curr Diab Rep       Date:  2018-05-24       Impact factor: 4.810

7.  Supporting self-care in general practice.

Authors:  Colin J Greaves; John L Campbell
Journal:  Br J Gen Pract       Date:  2007-10       Impact factor: 5.386

Review 8.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

9.  Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A J Jaap; M S Hammersley; A C Shore; J E Tooke
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

10.  The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.

Authors:  Justin B Echouffo-Tcheugui; Rebecca K Simmons; Kate M Williams; Roslyn S Barling; A Toby Prevost; Ann Louise Kinmonth; Nicholas J Wareham; Simon J Griffin
Journal:  BMC Public Health       Date:  2009-05-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.